Biotia today announced the launch of a new "test to treat" option for patients suffering from recurrent urinary tract infections (UTIs), moving UTI care forward. This solution allows patients to ...

Occasional urine leaks may seem harmless, but they can be signs of bladder or pelvic floor issues. A gynecologist explains why it is important not to ignore it.

Bundang Jesaeng Hospital is leading the global sharing medical practice.A Mongolian Tuggledur Monghgal (male, 9) child was ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's drug delivery system for a type of bladder cancer, ...

Inlexzo is inserted directly into the bladder where it remains for three weeks per treatment cycle for up to 14 cycles, the ...

The urology imaging systems market is projected to grow at a CAGR of 4% in the next five years. This growth is driven by the ...

Health experts have urged Nigerian women to adopt simple lifestyle and hygiene practices to reduce their risk of Urinary ...

A regulator has approved a world-first vaccine to protect koalas from chlamydia infections, which are causing infertility and ...

The U.S. Centers for Disease Control and Prevention intends to award the Rensselaer Polytechnic Institute a contract for ...

During National Prostate Health Month in September, Olympus Corp. of the Americas is proud to announce the new iTind™ Center of Excellence (COE) Program, which is designed to enhance care, experience ...

The FDA has approved Inlexzo (gemcitabine intravesical system) for the treatment of adult patients with BCG-unresponsive, non-muscle invasive bladder cancer with CIS with or without papillary tumors.